Epalrestat

CHEMBL56337 Phase 4 معتمد Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

319.4 g/mol

LogP

3.8

Phase

4

This medication blocks an enzyme involved in a pathway that becomes overactive in people with diabetes, helping to prevent nerve damage caused by high blood sugar. It is used to treat diabetic neuropathy.

الوزن الجزيئي

319,4000 g/mol

LogP

3,80

TPSA

115,00 Å²

قاعدة ليبينسكي للخمسة

ناجح

المجالات العلاجية

Pain Management Type 2 Diabetes Breast Cancer Chronic Pain

Pharmacokinetics (PK)

Pharmacodynamics (PD)

البنية ثنائية الأبعاد

SVG PNG

Cite this structure

Embed this structure

SMILES

CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1

InChI

InChI=1S/C15H13NO3S2/c1-10(7-11-5-3-2-4-6-11)8-12-14(19)16(9-13(17)18)15(20)21-12/h2-8H,9H2,1H3,(H,17,18)/b10-7+,12-8-

Molecular Formula

C15H13NO3S2

HBD / HBA

1 / 5

الروابط القابلة للدوران

4

الذرات الثقيلة

21

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

This medication blocks an enzyme involved in a pathway that becomes overactive in people with diabetes, helping to prevent nerve damage caused by high blood sugar. It is used to treat diabetic neuropathy.

Yes, Epalrestat is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL56337. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 1549120. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

هل تبحث عن معلومات ملائمة للمرضى؟

Epalrestat على PillFYI

البنية

بيانات سريعة

الصيغة الجزيئية: C15H13NO3S2

روابط خارجية

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.